NDLI: Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses

Content Provider	Springer Nature : BioMed Central
Author	Du, Haihong Zeng, Pengfei Liu, Xuyi Zhang, Jun Huang, Zhonglu
Abstract	Background Primary ovarian insufficiency (POI) is a disorder characterized by the premature decline in ovarian function, leading to significant fertility and health impacts on women under 40. The unclear etiology of POI hinders the development of effective treatments, highlighting the need for novel therapeutic targets. Methods This study employed genome-wide association analysis (GWAS) integrated with expression quantitative trait loci (eQTL) data from the GTEx and eQTLGen databases. Mendelian randomization (MR) and colocalization analyses were conducted to investigate causal relationships between genetic variants and POI and to identify potential therapeutic targets. Results We identified 431 genes with available index cis-eQTL signals, of which four (HM13, FANCE, RAB2A, and MLLT10) were significantly associated with POI. Colocalization analysis revealed strong evidence for FANCE and RAB2A, indicating their potential as therapeutic targets. Subsequent druggability assessments identified FANCE and RAB2A as promising candidates for POI treatment, supported by their involvement in DNA repair and autophagy regulation, respectively. Conclusions Our study establishes a causal link between specific genes and POI, highlighting FANCE and RAB2A as potential drug targets. These findings provide a foundation for future research and therapeutic development, aiming to improve outcomes for women with POI. Validation in further trials is necessary to confirm these potential targets.
Related Links	https://ovarianresearch.biomedcentral.com/counter/pdf/10.1186/s13048-024-01524-y.pdf
Ending Page	8
Page Count	8
Starting Page	1
File Format	HTM / HTML
ISSN	17572215
DOI	10.1186/s13048-024-01524-y
Journal	Journal of Ovarian Research
Issue Number	1
Volume Number	17
Language	English
Publisher	BioMed Central
Publisher Date	2024-10-02
Access Restriction	Open
Subject Keyword	Gynecology Reproductive Medicine Primary ovarian insufficiency Genome-wide Mendelian randomization Therapeutic target
Content Type	Text
Resource Type	Article
Subject	Oncology Obstetrics and Gynecology
Journal Impact Factor	3.8/2023
5-Year Journal Impact Factor	4.2/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum

A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa

The causal association between systemic inflammatory regulators and primary ovarian insufficiency: a bidirectional mendelian randomization study

Association of dietary preferences with primary ovarian insufficiency (POI): a mendelian randomization-based analysis

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.

Identifying key palmitoylation-associated genes in endometriosis through genomic data analysis

Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer

Causal association between metabolic syndrome and ovarian dysfunction: a bidirectional two-sample mendelian randomization

Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses

Similar Documents

Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum

A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa

The causal association between systemic inflammatory regulators and primary ovarian insufficiency: a bidirectional mendelian randomization study

Association of dietary preferences with primary ovarian insufficiency (POI): a mendelian randomization-based analysis

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses.

Identifying key palmitoylation-associated genes in endometriosis through genomic data analysis

Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer

Causal association between metabolic syndrome and ovarian dysfunction: a bidirectional two-sample mendelian randomization

Identifying therapeutic targets for primary ovarian insufficiency through integrated genomic analyses